ORKA

Oruka Therapeutics
ORKA

Overview Fund Trends Analyst Outlook Journalist POV

24 hedge funds and large institutions have $4.17M invested in Oruka Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

0.31% more ownership

Funds ownership: 0.66% → 0.97% (+0.31%)

92% less call options, than puts

Call options by funds: $328K | Put options by funds: $3.96M

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$328K
Puts
$3.96M
Net Calls
Net Calls Change

Top Buyers

1
+$568K
2
+$327K
3
+$126K
4
Millennium Management
Millennium Management
New York
+$120K
5
B
Bailard
California
+$87K

Top Sellers

1
-$55K
2
-$24.3K
3
-$13.9K
4
TRCT
Tower Research Capital (TRC)
New York
-$11K
5
Simplex Trading
Simplex Trading
Illinois
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
1
2